Concepedia

Risk factors for heart disease in transfusion-dependent thalassemia: serum ferritin revisited

Giorgio Derchi, Carlo Dessì, Patrizio Bina, Maria Domenica Cappellini, Antonio Piga, Silverio Perrotta, Immacolata Tartaglione, Marianna Giuditta, Filomena Longo, Raffaella Origa,

Internal and Emergency Medicine · 2018 · 19 citations · 19 references

DOI

Concepts

References

19

Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine.

Caterina Borgna‐Pignatti, Simone Rugolotto, Piero De Stefano et al. · PubMed · 2004 · 1.1K citations

, , +15

Survival in Medically Treated Patients with Homozygous β-Thalassemia

Nancy F. Olivieri, David G. Nathan, James H. MacMillan et al. · New England Journal of Medicine · 1994 · 864 citations · Full text

, , +15

Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance

Bernadette Modell, Maren Khan, Matthew Darlison et al. · Journal of Cardiovascular Magnetic Resonance · 2008 · 590 citations · Full text

, , +16

Cardiac T2* Magnetic Resonance for Prediction of Cardiac Complications in Thalassemia Major

Paul Kirk, John B. Porter, John M. Walker et al. · Circulation · 2009 · 586 citations · Full text

, , +9

Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis

Dudley J. Pennell · Blood · 2005 · 486 citations

, , +15